The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-08
DOI
10.1007/s40256-020-00407-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Atrial Fibrillation and Diabetes Mellitus
- (2019) Francis E. Ugowe et al. Circulation-Arrhythmia and Electrophysiology
- Effectiveness and Safety of Rivaroxaban and Warfarin for Prevention of Major Adverse Cardiovascular or Limb Events in Nonvalvular Atrial Fibrillation Patients with Type 2 Diabetes
- (2019) William L. Baker et al. DIABETES OBESITY & METABOLISM
- Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants
- (2019) Casper Binding et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation
- (2019) Pamela L. Lutsey et al. JAMA Internal Medicine
- Statins do not Increase the Rate of Bleeding Among Warfarin Users
- (2018) Maarit Jaana Korhonen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial
- (2018) Ajar Kochar et al. CLINICAL CARDIOLOGY
- Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysis
- (2018) C. I. Coleman et al. DIABETIC MEDICINE
- Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
- (2018) Paolo Gelosa et al. PHARMACOLOGICAL RESEARCH
- Is There a Preferred Stroke Prevention Strategy for Diabetic Patients with Non-Valvular Atrial Fibrillation? Comparing Warfarin, Dabigatran and Rivaroxaban
- (2018) Chih-Cheng Hsu et al. THROMBOSIS AND HAEMOSTASIS
- Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2018) Zhi-Chun Gu et al. Frontiers in Pharmacology
- A Machine Learning Aided Systematic Review and Meta-Analysis of the Relative Risk of Atrial Fibrillation in Patients With Diabetes Mellitus
- (2018) Zhaohan Xiong et al. Frontiers in Physiology
- Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
- (2018) Nijole Bernaitis et al. Journal of Clinical Medicine
- Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation
- (2018) Yi-Cheng Lin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Efficacy and Safety of Direct Oral Anticoagulants in Patients with Chronic Renal Insufficiency: A Review of the Literature
- (2018) Jacob Weber et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation
- (2017) Sayaka Namba et al. HEART AND VESSELS
- Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes
- (2017) Justin B. Echouffo-Tcheugui et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanism of Drug-Drug Interactions Between Warfarin and Statins
- (2016) Abdul Naveed Shaik et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
- (2015) Sameer Bansilal et al. AMERICAN HEART JOURNAL
- Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice
- (2015) Tomoya Hara et al. ATHEROSCLEROSIS
- The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis
- (2015) Qinmei Xiong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists: a self-controlled register study
- (2015) T. B. Stage et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2014) Jonathan L. Halperin et al. CIRCULATION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
- (2014) Adam Cuker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metformin use decreases the anticoagulant effect of phenprocoumon
- (2014) J. C. F. Wijnen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Worldwide Epidemiology of Atrial Fibrillation
- (2013) Sumeet S. Chugh et al. CIRCULATION
- Osteoporosis-associated Fracture and Diabetes
- (2013) Salila Kurra et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Absence of Clinically Relevant Interactions between Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - and Digoxin or Atorvastatin in Healthy Subjects
- (2013) D Kubitza et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis
- (2013) C. K. Kramer et al. BMJ-British Medical Journal
- Vascular calcification: The price to pay for anticoagulation therapy with vitamin K-antagonists
- (2012) Martijn L.L. Chatrou et al. BLOOD REVIEWS
- Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007
- (2012) Jonathan P. Piccini et al.
- Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation
- (2011) Jonas Bjerring Olesen et al. CHEST
- Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients
- (2011) B. Weijs et al. EUROPEAN HEART JOURNAL
- Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study
- (2011) Rachel R Huxley et al. HEART
- FRAX underestimates fracture risk in patients with diabetes
- (2011) Lora M Giangregorio et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women
- (2010) Mika Yamauchi et al. CLINICAL NUTRITION
- Vitamin K supplementation and progression of coronary artery calcium in older men and women
- (2009) M Kyla Shea et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- 2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group
- (2009) Andrea D. Furlan et al. SPINE
- Vitamin K-dependent Proteins, Warfarin, and Vascular Calcification
- (2008) J. Danziger Clinical Journal of the American Society of Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More